Benzodiazepines and Other Targeted Substances Regulations, SOR/2000-217
Section 35.3
Suspicious transaction
Cite as Benzodiazepines and Other Targeted Substances Regulations, SOR/2000-217, s. 35.3 · current to December 29, 2025 · regulation last amended December 19, 2025
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) A licensed dealer must provide a written report containing the following information to the Minister within 72 hours after becoming aware of a transaction occurring in the course of their activities that they have reasonable grounds to suspect may be related to the diversion of a targeted substance to an illicit market or use:
(a) their name, municipal address, telephone number and, if the licensed dealer is a corporation, the position held by the individual making the report;
(b) the name and municipal address of the other party to the transaction;
(c) details of the transaction, including its date and time, its type, the specified name and quantity of the targeted substance and, in the case of a product or compound, the quantity of every targeted substance that it contains;
(d) in the case of a product that contains the targeted substance, other than a test kit, the drug identification number that is assigned to the product under section C.01.014.2 of the Food and Drug Regulations, if any; and
(e) a detailed description of the reasons for those suspicions.
(2) No civil proceedings lie against a licensed dealer for having provided the report in good faith.
(3) A licensed dealer must not disclose that they have provided the report or disclose details of it, with the intent to prejudice a criminal investigation, whether or not a criminal investigation has begun.
Read the Benzodiazepines and Other Targeted Substances Regulations on the Justice Laws Website ↗
Made under Controlled Drugs and Substances Act, S.C. 1996, c. 19.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.